Boston to axe over 1,000 jobs as Q3 hints at turnaround
This article was originally published in Clinica
Executive Summary
Boston Scientific has announced another raft of job cuts on the eve of its third-quarter results, adding to some already hefty rounds of the axe in recent years. This time, the company plans to eliminate 1,100-1,500 of its 24,000-strong workforce as part of a 2014 restructuring plan aimed at saving $150-200m per year, according to a filing with the US Securities and Exchange Commission (SEC).
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.